Expanded Access Remdesivir (RDV; GS-5734™)
Condition(s):Coronavirus Disease 2019Last Updated:February 17, 2022No longer available
Hide Studies Not Open or Pending
Condition(s):Coronavirus Disease 2019Last Updated:February 17, 2022No longer available
Condition(s):Ebola; HIV/AIDSLast Updated:August 25, 2021Completed
Condition(s):COVID-19; Remdesivir; SARS-CoV-2Last Updated:April 15, 2020Terminated
Condition(s):EbolaLast Updated:February 15, 2022Completed
Condition(s):COVID-19Last Updated:December 31, 2020Completed
Condition(s):COVID-19Last Updated:January 26, 2021Completed
Condition(s):SARS-CoV2 InfectionLast Updated:November 13, 2020Approved for marketing
Condition(s):COVID-19; SARS-CoV-2Last Updated:April 15, 2020Suspended
Condition(s):COVID-19Last Updated:February 6, 2024Completed
Condition(s):SARS-CoV InfectionLast Updated:September 25, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.